SURGICAL PROCEDURES FOR KNEE OSTEOARTHRITIS-VOLUME AND COSTS AMONG THE COMMERCIALLY-INSURED PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Holy, C. E. [1 ]
Chitnis, A. S. [1 ]
Escarpeta-Soriano, J. [2 ]
Vanderkarr, M. [3 ]
Sparks, C. [4 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] DePuy Synth, W Chester, PA USA
[3] DePuy Synth Inc, Raynham, MA USA
[4] DePuy Synth Inc, W Chester, PA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD108
引用
下载
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [31] Epidemiology and treatment of chronic kidney disease among commercially-insured patients in the US
    Kauf, T.
    Wang, W.
    Dillon, A.
    Mikulski, H.
    Singh, I.
    Odegard, J.
    Ringemann, C.
    Haldrup, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S143 - S143
  • [32] Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
    Pollack, Michael
    Seal, Brian
    Joish, Vijay N.
    Cziraky, Mark J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1901 - 1911
  • [33] Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States
    Goodin, Douglas S.
    Corwin, Michael
    Kaufman, David
    Golub, Howard
    Reshef, Shoshana
    Rametta, Mark J.
    Knappertz, Volker
    Cutter, Gary
    Pleimes, Dirk
    PLOS ONE, 2014, 9 (08):
  • [34] Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States
    Zhou, Zhou
    Fan, Yanni
    Tang, Wenxi
    Liu, Xinyue
    Thomason, Darren
    Zhou, Zheng-Yi
    Macaulay, Dendy
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 920 - 927
  • [35] The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States
    Rice, J. Bradford
    White, Alan G.
    Galebach, Philip
    Korenblat, Kevin M.
    Wagh, Aneesha
    Lovelace, Belinda
    Wan, George J.
    Jamil, Khurram
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (08) : 1473 - 1480
  • [36] Current trends in osteoporosis epidemiology and the widening treatment gap among commercially-insured postmenopausal women in the United States (US)
    Kim, Min
    Samai, Peter
    Phelan, Matthew
    McDermott, Michele
    Deignan, Cynthia
    Lin, Tzu-Chieh
    Brookhart, Alan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 276 - 276
  • [37] Prevalence and impact of antipsychotic discontinuation among commercially-insured patients with bipolar disorder
    Khandker, Rezaul
    Chekani, Farid
    Limone, Brendan
    Riehle, Ellen
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 878 - 885
  • [38] Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States
    Zhou, Zhou
    Zhou, Zheng-Yi
    Kelkar, Sneha S.
    Sikirica, Vanja
    Xie, Jipan
    Grebla, Regina
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (04) : 585 - 592
  • [39] The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
    Ogbomo, Adesuwa
    Tsang, Yuen
    Mallampati, Rajesh
    Panjabi, Sumeet
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 608 - 616
  • [40] Naloxone dispensing among the commercially insured population in the United States
    Dunphy, Christopher
    Zhang, Kun
    Guy, Gery P., Jr.
    Jones, Christopher M.
    PREVENTIVE MEDICINE, 2021, 153
12345